Artwork

Contenu fourni par Drs. Brian Lenzkes & Tro Kalayjian, Dr. Brian Lenzkes, and Dr. Tro. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Drs. Brian Lenzkes & Tro Kalayjian, Dr. Brian Lenzkes, and Dr. Tro ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Episode 233: Dr. David Boulware

1:17:51
 
Partager
 

Manage episode 334033773 series 2464518
Contenu fourni par Drs. Brian Lenzkes & Tro Kalayjian, Dr. Brian Lenzkes, and Dr. Tro. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Drs. Brian Lenzkes & Tro Kalayjian, Dr. Brian Lenzkes, and Dr. Tro ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Thank you for joining us for another episode of the Low Carb MD Podcast. Dr. David Boulware is an infectious disease physician-scientist with formal training in clinical trials, public health, and tropical medicine. Dr. Boulware combines his clinical research with nested basic science investigations into disease pathogenesis to conduct translational research. His primary research interests are in meningitis in resource-limited areas including diagnosis, prevention, treatment, and quality improvement initiatives incorporating cost-effectiveness analyses in order to translate knowledge into improved care. Dr. Boulware’s current research is focused on improving the clinical outcomes of HIV-infected persons with cryptococcal meningitis, the second most common AIDS-defining opportunistic infection in Sub-Saharan Africa and the most common cause of adult meningitis. Dr. Boulware leads a multidisciplinary, international research team with active research collaborations with partners in Uganda, South Africa, Ethiopia, Brazil, Botswana, the Netherlands, and the United Kingdom.

In their conversation, Drs. Tro and David talk about how Dr. Boulware found his way into infectious disease, Dr. Boulware’s career following the advent of Covid, Hydroxychloroquine studies, Ivermectin studies, the Activ-6 trial, monoclonal antibody treatment, Emergency Use Authorization from the FDA, and Dr. Boulware’s take on the medical field post-Covid.

For more information, please see the links below. Thank you for listening!

Links:

Dr. David Boulware:

Dr. Brian Lenzkes:

Dr. Tro Kalayjian:

  continue reading

331 episodes

Artwork

Episode 233: Dr. David Boulware

Low Carb MD Podcast

135 subscribers

published

iconPartager
 
Manage episode 334033773 series 2464518
Contenu fourni par Drs. Brian Lenzkes & Tro Kalayjian, Dr. Brian Lenzkes, and Dr. Tro. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Drs. Brian Lenzkes & Tro Kalayjian, Dr. Brian Lenzkes, and Dr. Tro ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Thank you for joining us for another episode of the Low Carb MD Podcast. Dr. David Boulware is an infectious disease physician-scientist with formal training in clinical trials, public health, and tropical medicine. Dr. Boulware combines his clinical research with nested basic science investigations into disease pathogenesis to conduct translational research. His primary research interests are in meningitis in resource-limited areas including diagnosis, prevention, treatment, and quality improvement initiatives incorporating cost-effectiveness analyses in order to translate knowledge into improved care. Dr. Boulware’s current research is focused on improving the clinical outcomes of HIV-infected persons with cryptococcal meningitis, the second most common AIDS-defining opportunistic infection in Sub-Saharan Africa and the most common cause of adult meningitis. Dr. Boulware leads a multidisciplinary, international research team with active research collaborations with partners in Uganda, South Africa, Ethiopia, Brazil, Botswana, the Netherlands, and the United Kingdom.

In their conversation, Drs. Tro and David talk about how Dr. Boulware found his way into infectious disease, Dr. Boulware’s career following the advent of Covid, Hydroxychloroquine studies, Ivermectin studies, the Activ-6 trial, monoclonal antibody treatment, Emergency Use Authorization from the FDA, and Dr. Boulware’s take on the medical field post-Covid.

For more information, please see the links below. Thank you for listening!

Links:

Dr. David Boulware:

Dr. Brian Lenzkes:

Dr. Tro Kalayjian:

  continue reading

331 episodes

Tous les épisodes

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide